Menu
Back to User profile » Dr Yuankai Shi
Papers published by Dr Yuankai Shi:
A Remarkable and Durable Response to Sintilimab and Anlotinib in the First-Line Treatment of an Anaplastic Thyroid Carcinoma without Targetable Genomic Alterations: A Case Report
Gui L, Liu S, Zhang Y, Shi Y
OncoTargets and Therapy 2021, 14:2741-2746
Published Date: 20 April 2021
Characteristics and Management of TP53-Mutated Diffuse Large B-Cell Lymphoma Patients
Qin Y, Jiang S, Liu P, Yang J, Yang S, He X, Zhou S, Gui L, Lin J, Du X, Yi Y, Sun Y, Shi Y
Cancer Management and Research 2020, 12:11515-11522
Published Date: 10 November 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial
Liu YT, Hao XZ, Liu DR, Cheng G, Zhang SC, Xiao WH, Hu Y, Liu JF, He M, Ding CM, Zhang L, Wang J, Li H, Dong GL, Zhi XY, Li J, Shi YK
Cancer Management and Research 2020, 12:4633-4643
Published Date: 17 June 2020
Safety, tolerability, and pharmacokinetics of simotinib, a novel specific EGFR tyrosine kinase inhibitor, in patients with advanced non-small cell lung cancer: results of a phase Ib trial
Hu XS, Han XH, Yang S, Li N, Wang L, Song YY, Mu H, Shi YK
Cancer Management and Research 2019, 11:4449-4459
Published Date: 13 May 2019
Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study
Xu J, Liu X, Yang S, Zhang X, Shi Y
OncoTargets and Therapy 2017, 10:4989-4995
Published Date: 13 October 2017